230 related articles for article (PubMed ID: 28258214)
1. Identification of a feedback loop involving β-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease.
Schonauer S; Körschen HG; Penno A; Rennhack A; Breiden B; Sandhoff K; Gutbrod K; Dörmann P; Raju DN; Haberkant P; Gerl MJ; Brügger B; Zigdon H; Vardi A; Futerman AH; Thiele C; Wachten D
J Biol Chem; 2017 Apr; 292(15):6177-6189. PubMed ID: 28258214
[TBL] [Abstract][Full Text] [Related]
2. Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes.
Burke DG; Rahim AA; Waddington SN; Karlsson S; Enquist I; Bhatia K; Mehta A; Vellodi A; Heales S
J Inherit Metab Dis; 2013 Sep; 36(5):869-72. PubMed ID: 23151684
[TBL] [Abstract][Full Text] [Related]
3. Beta-glucosidase 1 (GBA1) is a second bile acid β-glucosidase in addition to β-glucosidase 2 (GBA2). Study in β-glucosidase deficient mice and humans.
Harzer K; Blech-Hermoni Y; Goldin E; Felderhoff-Mueser U; Igney C; Sidransky E; Yildiz Y
Biochem Biophys Res Commun; 2012 Jun; 423(2):308-12. PubMed ID: 22659419
[TBL] [Abstract][Full Text] [Related]
4. The non-lysosomal β-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi.
Körschen HG; Yildiz Y; Raju DN; Schonauer S; Bönigk W; Jansen V; Kremmer E; Kaupp UB; Wachten D
J Biol Chem; 2013 Feb; 288(5):3381-93. PubMed ID: 23250757
[TBL] [Abstract][Full Text] [Related]
5. Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish.
Lelieveld LT; Mirzaian M; Kuo CL; Artola M; Ferraz MJ; Peter REA; Akiyama H; Greimel P; van den Berg RJBHN; Overkleeft HS; Boot RG; Meijer AH; Aerts JMFG
J Lipid Res; 2019 Nov; 60(11):1851-1867. PubMed ID: 31562193
[TBL] [Abstract][Full Text] [Related]
6. Assay of β-glucosidase 2 (GBA2) activity using lithocholic acid β-3-O-glucoside substrate for cultured fibroblasts and glucosylceramide for brain tissue.
Harzer K; Yildiz Y; Beck-Wödl S
Biol Chem; 2019 May; 400(6):745-752. PubMed ID: 30864417
[TBL] [Abstract][Full Text] [Related]
7. Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.
Yildiz Y; Hoffmann P; Vom Dahl S; Breiden B; Sandhoff R; Niederau C; Horwitz M; Karlsson S; Filocamo M; Elstein D; Beck M; Sandhoff K; Mengel E; Gonzalez MC; Nöthen MM; Sidransky E; Zimran A; Mattheisen M
Orphanet J Rare Dis; 2013 Sep; 8():151. PubMed ID: 24070122
[TBL] [Abstract][Full Text] [Related]
8. Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2.
Boot RG; Verhoek M; Donker-Koopman W; Strijland A; van Marle J; Overkleeft HS; Wennekes T; Aerts JM
J Biol Chem; 2007 Jan; 282(2):1305-12. PubMed ID: 17105727
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1.
Akiyama H; Kobayashi S; Hirabayashi Y; Murakami-Murofushi K
Biochem Biophys Res Commun; 2013 Nov; 441(4):838-43. PubMed ID: 24211208
[TBL] [Abstract][Full Text] [Related]
10. Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease.
Hamler R; Brignol N; Clark SW; Morrison S; Dungan LB; Chang HH; Khanna R; Frascella M; Valenzano KJ; Benjamin ER; Boyd RE
Anal Chem; 2017 Aug; 89(16):8288-8295. PubMed ID: 28686011
[TBL] [Abstract][Full Text] [Related]
11. High β-glucosidase (GBA) activity not attributable to GBA1 and GBA2 in live normal and enzyme-deficient fibroblasts may emphasise the role of additional GBAs.
Harzer K; Yildiz Y
Biol Chem; 2015 Nov; 396(11):1241-6. PubMed ID: 25996484
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.
Barnes S; Xu YH; Zhang W; Liou B; Setchell KD; Bao L; Grabowski GA; Sun Y
PLoS One; 2014; 9(12):e116023. PubMed ID: 25551612
[TBL] [Abstract][Full Text] [Related]
13. Reducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C Mice.
Marques AR; Aten J; Ottenhoff R; van Roomen CP; Herrera Moro D; Claessen N; Vinueza Veloz MF; Zhou K; Lin Z; Mirzaian M; Boot RG; De Zeeuw CI; Overkleeft HS; Yildiz Y; Aerts JM
PLoS One; 2015; 10(8):e0135889. PubMed ID: 26275242
[TBL] [Abstract][Full Text] [Related]
14. Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease.
Mistry PK; Liu J; Sun L; Chuang WL; Yuen T; Yang R; Lu P; Zhang K; Li J; Keutzer J; Stachnik A; Mennone A; Boyer JL; Jain D; Brady RO; New MI; Zaidi M
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4934-9. PubMed ID: 24639522
[TBL] [Abstract][Full Text] [Related]
15. Impact of Gba2 on neuronopathic Gaucher's disease and α-synuclein accumulation in medaka (Oryzias latipes).
Nakanishi E; Uemura N; Akiyama H; Kinoshita M; Masanori S; Taruno Y; Yamakado H; Matsuzawa SI; Takeda S; Hirabayashi Y; Takahashi R
Mol Brain; 2021 May; 14(1):80. PubMed ID: 33971917
[TBL] [Abstract][Full Text] [Related]
16. Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal β-glucocerebrosidase.
Abdul-Hammed M; Breiden B; Schwarzmann G; Sandhoff K
J Lipid Res; 2017 Mar; 58(3):563-577. PubMed ID: 28126847
[TBL] [Abstract][Full Text] [Related]
17. Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease.
Meivar-Levy I; Horowitz M; Futerman AH
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):377-82. PubMed ID: 7980395
[TBL] [Abstract][Full Text] [Related]
18. Glucosylceramidases and malignancies in mammals.
Astudillo L; Therville N; Colacios C; Ségui B; Andrieu-Abadie N; Levade T
Biochimie; 2016 Jun; 125():267-80. PubMed ID: 26582417
[TBL] [Abstract][Full Text] [Related]
19. Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts.
Aureli M; Bassi R; Loberto N; Regis S; Prinetti A; Chigorno V; Aerts JM; Boot RG; Filocamo M; Sonnino S
J Inherit Metab Dis; 2012 Nov; 35(6):1081-91. PubMed ID: 22526844
[TBL] [Abstract][Full Text] [Related]
20. Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype.
Liou B; Zhang W; Fannin V; Quinn B; Ran H; Xu K; Setchell KDR; Witte D; Grabowski GA; Sun Y
Sci Rep; 2019 Apr; 9(1):5571. PubMed ID: 30944381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
